Vor Biopharma Inc.
Total Trades
13
Buys
1
Sells
12
Largest Trade
N/A
Insiders
3
Institutional Funds
36
Inst. Value
$1M+
Activist Filings
44
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | SELL | $1M+ | 400K | $25.90 | Oct 30, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | SELL | $1M+ | 221K | $28.06 | Oct 28, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | SELL | $1M+ | 117K | $29.34 | Oct 22, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $1M+ | 38K | $30.19 | Oct 21, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $500K+ | 447K | $1.54 | Sep 19, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $1M+ | 985K | $1.73 | Sep 15, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $1M+ | 1.3M | $1.95 | Sep 11, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $1M+ | 1.4M | $1.97 | Sep 5, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $1M+ | 1.4M | $2.01 | Aug 29, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | SELL | $1M+ | 672K | $2.10 | Aug 27, 2025 |
| Reprogrammed Interchange LLC | 10% Owner | BUY | N/A | 39.0M | — | Jan 3, 2025 |
| Attar Eyal C. | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 10K | $1.25 | Dec 31, 2024 |
| Attar Eyal C. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 15K | $1.39 | Jun 4, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 36 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 5.4M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 2.5M | $1M+ | SH |
| VR Adviser, LLC | 1.9M | $1M+ | SH |
| NEXTBio Capital Management LP | 1000K | $1M+ | SH |
| Caligan Partners LP | 925K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 410K | $1M+ | SH |
| Laurion Capital Management LP | 317K | $1M+ | SH |
| UBS Group AG | 245K | $1M+ | SH |
| FINDELL CAPITAL MANAGEMENT LLC | 231K | $1M+ | SH |
| TUDOR INVESTMENT CORP ET AL | 168K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 150K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 146K | $1M+ | SH |
| Logos Global Management LP | 100K | $1M+ | SH |
| VANGUARD GROUP INC | 94K | $1M+ | SH |
| JANE STREET GROUP, LLC | 92K | $1M+ | SH |
| STATE STREET CORP | 91K | $1M+ | SH |
| JOHNSON & JOHNSON | 54K | $500K+ | SH |
| Sarissa Capital Management LP | 25K | $100K–$500K | SH |
| Bollard Group LLC | 24K | $100K–$500K | SH |
| Hudson Bay Capital Management LP | 21K | $100K–$500K | SH (Call) |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
9.9%
4.3M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 17, 2026
9.9%
2.2M shares
SC 13G/A · Feb 17, 2026
3.3%
1.4M shares
Qiming Venture Partners VIII-HC, L.P.
SC 13G/A · Feb 14, 2026
2.8%
1.1M shares
SC 13G/A · Feb 5, 2026
6.5%
2.5M shares
SC 13D · Dec 23, 2025
10.0%
10.2M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G · Dec 19, 2025
5.8%
2.3M shares
SC 13D/A · Dec 18, 2025
14.0%
5.4M shares
SC 13G · Dec 17, 2025
5.6%
1.2M shares
Paradigm BioCapital Advisors LP
SC 13G · Nov 18, 2025
8.6%
1.8M shares
SC 13D/A · Nov 14, 2025
9.9%
2.3M shares
SC 13G · Nov 7, 2025
11.5%
788K shares
Qiming Venture Partners VIII Investments, LLC
SC 13G · Nov 5, 2025
4.5%
414K shares
SC 13D/A · Oct 30, 2025
11.5%
786K shares
SC 13D/A · Oct 28, 2025
17.3%
1.2M shares
SC 13D/A · Oct 20, 2025
20.9%
1.4M shares
SC 13D/A · Oct 17, 2025
17.6%
1.2M shares
SC 13D/A · Oct 16, 2025
18.6%
1.3M shares
SC 13D/A · Oct 10, 2025
20.1%
1.4M shares
SC 13D/A · Oct 8, 2025
21.9%
1.5M shares
SC 13D/A · Oct 6, 2025
23.3%
1.6M shares
SC 13G · Sep 26, 2025
9.9%
761K shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Sep 26, 2025
9.9%
761K shares
SC 13G · Sep 23, 2025
10.0%
7.0M shares
SC 13D/A · Sep 19, 2025
29.0%
2.0M shares
SC 13D/A · Sep 12, 2025
26.8%
33.9M shares
SC 13D/A · Sep 9, 2025
28.0%
35.5M shares
SC 13D/A · Aug 29, 2025
29.1%
36.9M shares
SC 13G/A · Aug 6, 2025
1.7%
2.1M shares
SC 13D/A · Jul 9, 2025
2.6%
3.2M shares
SC 13D/A · Jun 27, 2025
31.8%
39.7M shares
SC 13G/A · May 12, 2025
5.1%
6.4M shares
SC 13G/A · Feb 12, 2025
9.3%
6.4M shares
SC 13D · Jan 7, 2025
31.3%
39.0M shares
SC 13D/A · Dec 30, 2024
31.9%
39.7M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13D/A · Feb 14, 2024
6.8%
4.6M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13D/A · Aug 11, 2023
33.7%
22.8M shares
SC 13G/A · Jan 10, 2023
12.1%
8.0M shares
SC 13D/A · Dec 9, 2022
34.8%
22.8M shares
SC 13D/A · Nov 14, 2022
28.8%
11.1M shares